Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis

Autor: Nicholas Fuggle, Nasser Al-Daghri, Olivier Bock, Jaime Branco, Olivier Bruyère, Enrique Casado, Etienne Cavalier, Bernard Cortet, Maarten de Wit, Andrea Giusti, Philippe Halbout, Nicholas C. Harvey, Mickaël Hiligsmann, Jean-Marc Kaufman, Andreas Kurth, Stefania Maggi, Radmila Matijevic, Salvatore Minisola, Santiago Palacios, Régis Pierre Radermecker, Friederike Thomasius, Sansin Tuzun, Nicola Veronese, John A. Kanis, Jean-Yves Reginster, René Rizzoli, Cyrus Cooper

Publikováno v: Fuggle, Nicholas; Al-Daghri, Nasser; Bock, Olivier; Branco, Jaime; Bruyère, Olivier; Casado, Enrique; Cavalier, Etienne; Cortet, Bernard; de Wit, Maarten; Giusti, Andrea; Halbout, Philippe; Harvey, Nicholas C; Hiligsmann, Mickaël; Kaufman, Jean-Marc; Kurth, Andreas; Maggi, Stefania; Matijevic, Radmila; Minisola, Salvatore; Palacios, Santiago; Radermecker, Régis Pierre; ... (2023). Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging clinical and experimental research, 35(6), pp. 1375-1376. Springer 10.1007/s40520-022-02319-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e75bd74554a5cde7d8ee52d182ee0656
https://boris.unibe.ch/176787/1/s40520-022-02319-1.pdf

Novel formulations of oral bisphosphonates in the treatment of osteoporosis

Autor: Nicholas Fuggle, Nasser Al-Daghri, Olivier Bock, Jaime Branco, Olivier Bruyère, Enrique Casado, Etienne Cavalier, Bernard Cortet, Maarten de Wit, Andrea Giusti, Philippe Halbout, Nicholas C. Harvey, Mickaël Hiligsmann, Jean-Marc Kaufman, Andreas Kurth, Stefania Maggi, Radmila Matijevic, Salvatore Minisola, Santiago Palacios, Régis Pierre Radermecker, Friederike Thomasius, Sansin Tuzun, Nicola Veronese, John A. Kanis, Jean-Yves Reginster, René Rizzoli, Cyrus Cooper

Publikováno v: Fuggle, Nicholas; Al-Daghri, Nasser; Bock, Olivier; Branco, Jaime; Bruyère, Olivier; Casado, Enrique; Cavalier, Etienne; Cortet, Bernard; de Wit, Maarten; Giusti, Andrea; Halbout, Philippe; Harvey, Nicholas C; Hiligsmann, Mickaël; Kaufman, Jean-Marc; Kurth, Andreas; Maggi, Stefania; Matijevic, Radmila; Minisola, Salvatore; Palacios, Santiago; Radermecker, Régis Pierre; ... (2022). Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging clinical and experimental research, 34(11), pp. 2625-2634. Springer 10.1007/s40520-022-02272-z

Oral bisphosphonates are a key intervention in the treatment of osteoporosis and in reducing the risk of fragility fractures. Their use is supported by over 3 decades of evidence; however, patient adherence to oral bisphosphonates remains poor in par

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb27608bf6b9e95b73c8c03e1b78f2ff
https://hdl.handle.net/10447/582713

Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations

Autor: Nicola Veronese, Cyrus Cooper, Olivier Bruyère, Nasser M. Al-Daghri, Jaime Branco, Etienne Cavalier, Sara Cheleschi, Mario Coelho da Silva Rosa, Philip G. Conaghan, Elaine M. Dennison, Maarten de Wit, Antonella Fioravanti, Nicholas R. Fuggle, Ida K. Haugen, Gabriel Herrero-Beaumont, Germain Honvo, Andrea Laslop, Radmila Matijevic, Alberto Migliore, Ali Mobasheri, Jean-Pierre Pelletier, María Concepción Prieto Yerro, Régis Pierre Radermecker, François Rannou, René Rizzoli, Jean-Yves Reginster

Publikováno v: Drugs. 82(13)

© The Author(s) 2022 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::785d6766642dab67a197b773f5b8bf2f
https://pubmed.ncbi.nlm.nih.gov/36255688

[Artificial pancreas: where are we in 2020 ?]

Autor: Régis Pierre, Radermecker

Publikováno v: Revue medicale suisse. 16(703)

The artificial pancreas is a system coupling an automatic insulin infusion according to a continuous glucose monitoring. It is mainly intended for type 1 diabetic patients. Many advances in this area have led to the commercialization of so-called hyb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6ecc57f2704aa5ffdb09ba71ad14fd15
https://pubmed.ncbi.nlm.nih.gov/32852170